Qlife Holding AB (FRA:4HG0) ROCE %: -428.15% (As of Mar. 2026)


FRA:4HG0 Qlife Holding AB FRA:4HG0
25 GF Score
Price €0.15
GF Value €0.06
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Qlife Holding AB ROCE %?

Qlife Holding AB FRA:4HG0 -5.62% 25 ROCE % is -428.15% as of Mar. 2026. GuruFocus rates FRA:4HG0 with a GF Score™ of 25/100 and a GF Value™ of €0.06 (Significantly Overvalued). The stock has 9 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Qlife Holding AB's annualized ROCE % for the quarter that ended in Mar. 2026 was -428.15%.

Qlife Holding AB  (FRA:4HG0) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Qlife Holding AB ROCE % Related Terms

Qlife Holding AB ROCE % Historical Data

* Premium members only.

The historical data trend for Qlife Holding AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qlife Holding AB ROCE % Chart

Qlife Holding AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -46.17 -67.39 -248.37 0.00 -522.03

Qlife Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -292.89 -361.49 -831.35 -401.13 -428.15
FRA:4HG0
25GF Score
Qlife Holding AB FRA:4HG0
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qlife Holding AB ROCE % Calculation

Qlife Holding AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-1.801/( ( (1.013 - 0.38) + (0.885 - 0.828) )/ 2 )
=-1.801/( (0.633+0.057)/ 2 )
=-1.801/0.345
=-522.03 %

Qlife Holding AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-2.16/( ( (0.885 - 0.828) + (1.374 - 0.422) )/ 2 )
=-2.16/( ( 0.057 + 0.952 )/ 2 )
=-2.16/0.5045
=-428.15 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -428.15% mean?
Qlife Holding AB (FRA:4HG0) has a ROCE % of -428.15% as of Mar. 2026.
Is Qlife Holding AB's ROCE % too high?
Qlife Holding AB's current ROCE % is -428.15%. Overall, Qlife Holding AB has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's ROCE % compare to ABT and SYK?
Qlife Holding AB's ROCE % of -428.15% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qlife Holding AB's current ROCE % is -428.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (FRA:4HG0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.06, compared to a current price of €0.15 — trading 152% above its estimated fair value. The current ROCE % is -428.15%. Qlife Holding AB's overall GF Score™ is 25/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Qlife Holding AB (FRA:4HG0), the current ROCE % is -428.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qlife Holding AB (FRA:4HG0) Overvalued in 2026?

Based on GuruFocus' analysis, Qlife Holding AB stock appears to be overvalued. The current stock price of €0.15 is trading 152% above its estimated GF Value™ of €0.06. GuruFocus considers Qlife Holding AB to be Significantly Overvalued.

Key valuation signals for FRA:4HG0:

  • ROCE %: -428.15%
  • GF Value™: €0.06 vs. price of €0.15 (152% above fair value)
  • GF Score™: 25/100 with 9 warning signs

No single metric tells the full story. See the FRA:4HG0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qlife Holding AB Business Description

Other Exchanges QLIFE:Sweden
Address Nellikevagen 22, Goteborg, SWE, SE-412 63
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
25GF Score

Get the complete analysis for FRA:4HG0

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price
€0.06
GF Value